Artificial Intelligence Shows Strong Potential to Transform Breast Cancer Detection, Major Systematic Review Finds

2026-06-08 03:07:02 Education

161

A new systematic review published in the Asian Journal of Medicine and Health highlights the growing promise of artificial intelligence (AI) in breast cancer detection and diagnosis. The study, “Diagnostic Accuracy of Artificial Intelligence for Breast Cancer Detection: A Systematic Review,” found that AI and machine learning technologies consistently demonstrated strong diagnostic performance across multiple imaging methods, including mammography, ultrasound, magnetic resonance imaging (MRI), thermography, and digital pathology.

The findings suggest that AI could become an important clinical support tool, helping healthcare professionals identify breast cancer earlier, improve diagnostic consistency, and increase the efficiency of screening programs. As healthcare systems worldwide face rising patient volumes and increasing demands on specialists, AI-assisted diagnosis may help address critical challenges in cancer care.

Addressing a Global Health Challenge

Breast cancer remains one of the most commonly diagnosed cancers among women worldwide. Early detection is crucial because it improves survival rates and expands treatment options. However, traditional diagnostic approaches can face challenges, including variability in image interpretation, reduced sensitivity in women with dense breast tissue, and growing workloads for radiologists.

Artificial intelligence offers a promising solution by analyzing large amounts of medical data and identifying patterns that may be difficult for humans to detect. Researchers have increasingly explored AI-driven tools to support clinical decision-making and improve diagnostic accuracy.

Key Findings

The research team reviewed studies published between 2014 and 2025 and analyzed 29 studies that met strict eligibility criteria.

Major findings included:

• AI models demonstrated strong diagnostic performance across a variety of breast imaging technologies.
• Deep learning models, particularly Convolutional Neural Networks (CNNs), were the most widely used and frequently achieved the best results.
• Many studies reported sensitivity and specificity rates exceeding 85%.
• Area Under the Curve (AUC), a widely used measure of diagnostic performance, ranged from 84% to as high as 99%.
• AI-assisted mammography performed comparably to traditional double-reading approaches while helping reduce radiologist workload.
• Several studies reported improved cancer detection rates and increased screening efficiency through AI-assisted analysis.

The review also found that combining imaging data with clinical or genetic information often enhanced diagnostic performance beyond what imaging alone could achieve.

Benefits Beyond Diagnosis

Researchers noted that AI applications are expanding beyond cancer detection into other areas of breast cancer care. Several studies demonstrated AI's potential to predict treatment response, assess disease progression, support radiotherapy planning, and contribute to more personalized treatment strategies.
These findings suggest that AI could eventually play a role throughout the entire breast cancer care pathway, from screening and diagnosis to treatment planning and long-term patient management.

How the Research Was Conducted

The systematic review followed internationally recognized PRISMA guidelines. Researchers searched major scientific databases and assessed studies reporting measures such as sensitivity, specificity, accuracy, and AUC. Due to differences among study designs and methodologies, the researchers conducted a qualitative synthesis rather than a pooled statistical analysis.

Challenges and Future Directions

Despite the encouraging results, the authors caution that important challenges remain before AI can be fully integrated into routine clinical practice. Many studies relied on retrospective datasets and lacked extensive external validation across diverse populations.

The review also highlights concerns related to algorithmic bias, patient privacy, transparency, and regulatory oversight. The authors emphasize the need for prospective multicenter studies, standardized reporting practices, and robust validation frameworks.

According to the researchers, artificial intelligence has substantial potential to improve breast cancer screening, diagnosis, prognosis, and treatment planning. With continued research and responsible implementation, AI could become an increasingly valuable partner in helping clinicians detect breast cancer earlier and improve patient outcomes worldwide.

About the Study

This systematic review evaluated the diagnostic accuracy and clinical applicability of artificial intelligence and machine learning models used in breast cancer detection. By synthesizing evidence from 29 studies conducted across multiple countries and healthcare settings, the review provides a comprehensive overview of the opportunities and challenges associated with AI-assisted breast cancer diagnosis.

References

Kshatri, A. H. S., Parmar, S., Devarapalli, J., Nayak, K., Soumya., V., Basheer, K. B. R., … Kular, S. (2026). Diagnostic Accuracy of Artificial Intelligence for Breast Cancer Detection: A Systematic Review. Asian Journal of Medicine and Health, 24(5), 21–38. https://journalajmah.com/index.php/AJMAH/article/view/1387

Uzun Ozsahin, D., Ikechukwu Emegano, D., Uzun, B., & Ozsahin, I. (2022). The Systematic Review of Artificial Intelligence Applications in Breast Cancer Diagnosis. Diagnostics (Basel, Switzerland), 13(1), 45. https://doi.org/10.3390/diagnostics13010045